Authors:
Oka, R
Sasagawa, T
Ninomiya, I
Miwa, K
Tanii, H
Saijoh, K
Citation: R. Oka et al., Reduction in the local expression of complement component 6 (Cd) and 7 (C7) mRNAs in oesophageal carcinoma, EUR J CANC, 37(9), 2001, pp. 1158-1165
Authors:
Vestling, M
Wiehager, B
Tanii, H
Cowburn, RF
Citation: M. Vestling et al., Akt activity in presenilin 1 wild-type and mutation transfected human SH-SY5Y neuroblastoma cells after serum deprivation and high glucose stress, J NEUROSC R, 66(3), 2001, pp. 448-456
Citation: H. Tanii et T. Horie, Uptake of barbituric acid derivatives in small intestinal brush border membrane vesicles from retinyl palmitate-treated rats, PHARM TOX, 87(2), 2000, pp. 79-83
Authors:
Fuse, E
Hashimoto, A
Sato, N
Tanii, H
Kuwabara, T
Kobayashi, S
Sugiyama, Y
Citation: E. Fuse et al., Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01from human alpha(1)- acid glycoprotein, PHARM RES, 17(5), 2000, pp. 553-564
Citation: H. Tanii et al., Fos induction in the brain of mice exhibiting behavioral abnormalities following administration of allylnitrile or crotononitrile, BRAIN RES, 868(1), 2000, pp. 141-146
Authors:
Zang, XP
Tanii, H
Kobayashi, K
Higashi, T
Oka, R
Koshino, Y
Saijoh, K
Citation: Xp. Zang et al., Behavioral abnormalities and apoptotic changes in neurons in mice brain following a single administration of allylnitrile, ARCH TOXIC, 73(1), 1999, pp. 22-32
Citation: H. Tanii et T. Horie, Enhancement of glucose transport in small intestinal brush border membraneof retinol administered rat, LIFE SCI, 64(15), 1999, pp. 1259-1264
Authors:
Fuse, E
Tanii, H
Takai, K
Asanome, K
Kurata, N
Kobayashi, H
Kuwabara, T
Kobayashi, S
Sugiyama, Y
Citation: E. Fuse et al., Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha(1)-acid glycoprotein in humans, CANCER RES, 59(5), 1999, pp. 1054-1060